Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 12:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Arthritis, Diabetes Mellitus, Fractures, Hypertension, Depression, Urinary Incontinence
Interventions: Not listed
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 65 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1993 – 2000
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Glaucoma, Age Related Macular Degeneration, Optic Neuropathy, Retinal Degeneration
Interventions: nGoggle; Device
Lead sponsor: NGoggle; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 200 participants
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Renal Failure Chronic Requiring Hemodialysis
Interventions: intensive sodium management; Other
Lead sponsor: Renal Research Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 3
States / cities: New York, New York

Conditions: Focus Chronic Kidney Disease With Hypertension
Interventions: Exercise; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Hypertension
Interventions: Amiloride, Triamterene; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 65 Years and older
Enrollment: 155,963 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Preeclampsia
Interventions: Norethindrone 0.35 MG, Drospirenone; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Hypertension
Interventions: Ambulatory Blood Pressure Monitoring; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Arteriovenous Malformation, Gastrointestinal Bleed, Gastric Varices, Hemorrhoid, Pelvic Venous Disorders, Peripheral Aneurysms, Portal Vein Embolization, Type II Endoleak, Varicocele, Hemorrhage
Interventions: Concerto Versa™ Detachable Coils; Device
Lead sponsor: Medtronic Endovascular; Industry
Eligibility: 22 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 3
States / cities: Piscataway, New Jersey • New York, New York • El Paso, Texas

Conditions: Pulmonary Arterial Hypertension
Interventions: Esuberaprost, Placebo; Drug
Lead sponsor: Lung Biotechnology PBC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 43
States / cities: Birmingham, Alabama • Beverly Hills, California • La Jolla, California + 37 more

Conditions: High Risk Pregnancy, Remote Patient Monitoring, Diabetes, Hypertension
Interventions: Fetal ECG monitoring; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
Interventions: Treprostinil sodium for inhalation; Drug
Lead sponsor: Lung Biotechnology PBC; Industry
Eligibility: 35 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 6
States / cities: La Jolla, California • Sacramento, California • Ann Arbor, Michigan + 3 more

Conditions: RV - Right Ventricular Abnormality, LV Dysfunction, Pulmonary Hypertension, TOF
Interventions: Not listed
Lead sponsor: HBI Solutions Inc.; Industry
Eligibility: Up to 18 Years
Enrollment: 3,993 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pigmentary Glaucoma, Primary Open Angle Glaucoma, Cataract
Interventions: Trabeculectomy, Trabeculectomy and cataract surgery, Cataract surgery; Procedure
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 85 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Pulmonary Arterial Hypertension
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hypertension
Interventions: Best Practice Clinic-Based Care, Telehealth Care; Other
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 85 Years
Enrollment: 3,071 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Bloomington, Minnesota

Conditions: Sarcoidosis, Pulmonary Hypertension
Interventions: Ambrisentan; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 99 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Charleston, South Carolina

Conditions: Hypertension, Insulin Resistance
Interventions: Para-aminohippuric Acid, Angiotensin II, Norepinephrine; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Masked Hypertension, Hypertension, Chronic Renal Insufficiency
Interventions: Antihypertensive medication intensification, Usual care; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 75 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder), Connective Tissue Diseases
Interventions: 129Xe Hyperpolarized; Drug
Lead sponsor: Bastiaan Driehuys; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Gestational Diabetes Mellitus, Hypertension in Pregnancy, Dysglycemia
Interventions: OB Provider Clinical Decision Support (CDS), Patient Education (OB Visit), Text messaging, Patient Outreach, Primary Care Provider Clinical Decision Support (CDS), Patient Education (Primary Care Visit); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2,306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Primary Open-Angle Glaucoma
Interventions: Stents, Laser, Laser Trabeculoplasty; Device · Procedure
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 35 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 9
States / cities: Glendale, Arizona • Fayetteville, Arkansas • Hemet, California + 6 more

Conditions: Pulmonary Hypertension
Interventions: Nicotinamide Riboside (NR), Placebo; Dietary Supplement · Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Hypertension
Interventions: Intervention Group; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 110 Years
Enrollment: 278 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension, Vascular Diseases, Cardiovascular Diseases
Interventions: Symplicity Spyral™ multi-electrode renal denervation system, Sham Procedure; Device · Procedure
Lead sponsor: Medtronic Vascular; Industry
Eligibility: 20 Years to 80 Years
Enrollment: 337 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 32
States / cities: Huntsville, Alabama • Stanford, California • New Haven, Connecticut + 26 more

Search by objective public record fields.

Use of Complementary and Alternative Medicine Among Older Mexican Americans

Assessment of Visual Function With a Portable Brain-computer Interface

Effects of Intensified Sodium Management in Hemodialysis Patients

Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Amiloride vs Triamterene

A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia

Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II

Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils

A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension

Remote Fetal Monitoring in High Risk Pregnancies

Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Pediatric Ventricle Function Assessment Study

Autoimmune Dysregulation in Pigmentary Glaucoma

Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension

Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension

Caveolin-1 and Vascular Dysfunction

Treatment of Masked Hypertension

129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)

Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension

A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System